InsiderTrades

Form 4 for NBIX NEUROCRINE BIOSCIENCES INC

Accepted 2025-11-06 00:00:00 ET · period of report 2025-11-05 · accession 0001205903-25-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-06 2025-11-05 NBIX RASTETTER WILLIAM H Dir M - OptEx $47.89 +18.0K 58.4K +45% +$862.0K
D 2025-11-06 2025-11-05 NBIX RASTETTER WILLIAM H Dir S - Sale+OE $151.82 -18.0K 40.4K -31% -$2.73M
D 2025-11-06 2025-11-05 NBIX RASTETTER WILLIAM H Dir M - OptEx $0.00 -18.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-05 M A 18,000 $47.89 58,360 D — —
2 Common Common Stock 2025-11-05 S D 18,000 $151.82 40,360 D — — (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $153.01. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. (F3) 40,360 of the reported shares are held by the Rastetter Family Trust established September 2, 2010, of which the Reporting Person has voting and investment power.
3 Derivative Non-Qualified Stock Option 2025-11-05 M D 18,000 $0.00 0 D $47.89 · — to 2026-05-20 18,000 Common Stock (F4) The option was granted May 20, 2016 and vested in 12 equal monthly installments beginning June 20, 2016. These options were due to expire on May 20, 2026.